DRUG · Mapped RxNorm record
Vortioxetine
Normalized identity: vortioxetineView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)
NCT02371980
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedVortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
VortioxetineDRUG · verified · RxNorm: vortioxetine
PlaceboDRUG
Sponsors & collaborators
Takedalead sponsor
Mapped research locations
San DiegoCalifornia, United States3New YorkNew York, United States2HoustonTexas, United States2AtlantaGeorgia, United States2PortlandOregon, United States2Oklahoma CityOklahoma, United States2AustinTexas, United States2BostonMassachusetts, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02371980 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.